Latest News about pharmaceuticals
Recent news which mentions pharmaceuticals
Tickers
INNO
From Business Journals
Japan reports first case of mysterious children's liver disease as health experts explore possible Covid links
April 26, 2022
From CNBC.com News
From CNBC.com News
From Business Journals
From Business Journals
Tickers
INNO
From Business Journals
From CNBC.com News
From CNBC.com News
South Side life sciences company makes acquisition
April 20, 2022
From Business Journals
Why studying regenerative medicine should be studed in space and how it can help Winston-Salem
April 19, 2022
Tickers
INNO
From Business Journals
From Business Journals
Lab Notes: Oncora Medical doubles its client base; Context Therapeutics posts promising cancer drug data
April 15, 2022
Tickers
INNO
From Business Journals
Antares Pharma to be acquired by Halozyme in $960M deal
April 13, 2022
From Business Journals
From Business Journals
Ocugen's study of Covid-19 vaccine Covaxin put on hold in wake of WHO inspection of Bharat
April 12, 2022
From Business Journals
From Business Journals
Lab Notes: Venatorx closes Series C financing; Ocugen takes 'critical' step in clinical trial
April 08, 2022
Tickers
INNO
From Business Journals
From Business Journals
Pharma giant Pfizer acquires Durham drugmaker for $525M
April 07, 2022
From Business Journals
Strategic Thinking: With Eli Lilly CFO Anat Ashkenazi
April 07, 2022
From CNBC.com News
Tickers
INNO
From Business Journals
Gene therapy developer bluebird bio to cut 30% of staff
April 05, 2022
From Business Journals
Lab Notes: Jazz agrees to multimillion-dollar drug sale; Lannett takes 'major step' with biosimilar
April 01, 2022
Tickers
INNO
From Business Journals
Six questions with Incyclix Bio CEO Patrick Roberts
March 31, 2022
Tickers
INNO
From Business Journals
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
